K.C., a 44 year-old woman, called me from upstate New York. Over the past 15 years her uterus has gradually enlarged to the size of a seven month pregnancy due to the presence of multiple fibroids. She also suffered from asthma and her markedly enlarged uterus was contributing to her breathing difficulties. Her periods had become progressively heavier, leading to anemia.
K.C., a 44 year-old woman, called me from upstate New York. Over the past 15 years her uterus has gradually enlarged to the size of a seven month pregnancy due to the presence of multiple fibroids. She also suffered from asthma and her markedly enlarged uterus was contributing to her breathing difficulties. Her periods had become progressively heavier, leading to anemia. K.C. had been offered hysterectomy on multiple occasions but she resisted this suggestion. Her physical condition continued to deteriorate as she searched for a physician who would be willing and able to perform uterine-sparing surgery in her circumstances. I told K.C. that I had successfully treated other women with similar problems, but that, of course, I needed to review her records and examine her before making any decision regarding her care.
The following week I met K.C. and her husband for a complete evaluation. Upon review of her symptoms, K.C. indicated that in addition to feeling weak and short of breath, she suffered from abdominal pain, pelvic pressure, severe constipation and difficulty with urination. Pelvic examination and vaginal ultrasound revealed that she had multiple fibroids. The largest mass was located deep in the pelvis causing distortion of the cervix and other nearby structures. There was evidence of pressure on the bladder and rectum, accounting for her symptoms. Lab tests confirmed that K.C. was indeed very anemic from chronic, heavy blood loss.
K.C. and her husband were relieved to hear my assessment that uterine-sparing was feasible. However, I advised them, that because of the anemia and the size and location of the tumors, it would be best to postpone surgery until after a four-month course of medical therapy. This therapy consisted of a hormone called Lupron which would help shrink the tumors and reduce bleeding during the periods, as well as iron supplements to treat her anemia. We agreed that we would remain in touch with regard to her progress during this course of therapy.
Four months later, her anemia improved, K.C. underwent surgery. A total of 11 fibroid tumors, up to 6 inches in size, were removed through a bikini-type incision in her lower abdomen. The operation proceeded smoothly with only minimal blood loss. K.C. was discharged from the hospital two days later and was able to fly back home with her husband after resting in a hotel for two more days. K.C. reported to me that her life was vastly improved. A check up with her local physician revealed that her uterus was of normal size and she was no longer anemic. In addition, her asthma had become more easy to manage.
Study shows a healthy prenatal diet could be upstream obesity prevention strategy
December 26th 2024"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ranges."
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Early pregnancy cannabis use high in states with recreational legalization
November 11th 2024A population-based time-series analysis California before, during and after legalization show a rising trend in women using cannabis while pregnancy especially when the state has legalized the drug.
Read More
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More